H1 raised $40 million in a funding round led by CVS Health Ventures to enhance its AI-powered platform that connects patients with the right healthcare providers. This investment follows successful collaborations improving healthcare provider directory accuracy, aiming to simplify and speed up access to care. H1 serves major pharmaceutical companies and health plans, and plans to continue expanding its impact on healthcare efficiency and patient experience. The funding will support further innovation and growth in AI-driven healthcare solutions.
CVS Health received the 2026 Newsweek AI Impact Award in the AI Health Care category for its AI-Driven Prescription Interpretation and Instruction Standardization technology. This AI system automates complex prescription processing, enhancing medicat...
UnitedHealthcare announced it will remove two-thirds of prior authorization requirements for health plan members under 18 by the end of 2026. This change affects many diagnostic services, routine surgeries, and specialty pediatric care, aiming to sim...
Aetna, part of CVS Health, announced the launch of Aetna Mental Health On Demand, a service starting in 2027 that offers members aged 13 and older real-time access to licensed mental health clinicians via chat, phone, or video. This service aims to s...
CVS Health and Salesforce have expanded their collaboration to improve call center interactions for CVS members and providers using Salesforce's AI-driven Agentforce Health platform. This platform integrates AI agents with human support to provide re...
CVS Health will restore coverage of Eli Lilly's weight loss injection Zepbound starting October 1 and begin covering Lilly's new obesity pill Foundayo from June 1 on its standard drug plans. This move balances coverage between Eli Lilly and Novo Nord...
